Results 131 to 140 of about 796,231 (315)

Identification of Post-Ictal Generalised EEG Suppression with Two-Channel EEG

open access: yesSensors
This study investigates the feasibility of using a two-channel subcutaneous EEG device (SubQ) to detect and monitor PGES. The SubQ device, developed by UNEEG Medical A/S, offers a minimally invasive alternative to scalp EEG, enabling ultra-long-term ...
Joe Davies   +5 more
doaj   +1 more source

Comparative clinical utility of once-weekly subcutaneous abatacept in the management of rheumatoid arthritis

open access: yes, 2014
Chadi Rakieh, Philip G ConaghanLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, UKAbstract: Biologic therapies in rheumatoid arthritis are now part of standard ...
Conaghan PG, Rakieh C
core  

Making the Case for Organ‐on‐Chip Platforms in Long‐Acting Therapeutics Development

open access: yesAdvanced Healthcare Materials, EarlyView.
LATs release drug from a tissue‐resident depot over weeks to months, improving adherence, but their development is hampered by preclinical models that cannot reproduce the coupled tissue processes, sustained release, local microenvironment change, interstitial transport, immune and foreign‐body responses, and clearance that govern depot performance in ...
Charlie Gowans   +7 more
wiley   +1 more source

Subcutaneous rhinosporidiosis

open access: yesIndian Journal of Dermatology, 2008
Nayak Surajit   +3 more
openaire   +3 more sources

2‐Deoxyglucose Dendrimer‐Enabled Niclosamide Delivery to FRβ‐Expressing Macrophages Alleviates Endometriosis Progression and Associated Hyperalgesia

open access: yesAdvanced Healthcare Materials, EarlyView.
A folic acid (FA)‐conjugated 2‐deoxyglucose dendrimer selectively targets FRβ+ macrophages in endometriotic lesions, enabling precise intracellular delivery of niclosamide. This nonhormonal nanomedicine enhances drug solubility, provides controlled intracellular release, suppresses lesion growth, reduces inflammation and pain, and establishes FRβ ...
Anubhav Dhull   +11 more
wiley   +1 more source

Advancing Human Skin Equivalents: The Crucial Role of Neurovascular Integration

open access: yesAdvanced Healthcare Materials, EarlyView.
This review discusses the importance of integrating vascular and peripheral nerve systems into human skin equivalents (HSEs) to better recapitulate native skin physiology. Recent advances in vascularized, innervated, and neurovascularized HSEs are highlighted, together with emerging bioengineering strategies, current challenges, and future ...
Hao Wu   +4 more
wiley   +1 more source

Tolerability of immunoglobulin products and outcomes after product switching: a single-center real-world retrospective study

open access: yesFrontiers in Immunology
ObjectivesWe assessed the frequency of adverse drureactions (ADRs) to immunoglobulin products, associated switching patterns, and tolerability after switching in clinical practice.MethodsThis observational, retrospective study was conducted at a single ...
Paulina Vásquez-Reyes   +6 more
doaj   +1 more source

Magnetically Driven Biofabrication for Tissue Engineering: From Nanoparticle Design to Mag‐ATMP Translation

open access: yesAdvanced Healthcare Materials, EarlyView.
Magnetically responsive nanoparticles enable remote control over biomaterials, cells, and engineered tissues. This review summarizes material design, biological safety, fabrication and actuation strategies, computational validation, and translational pathways that support the development of magnetic tissue‐engineering platforms and future magnetically ...
Konstantinos Ioannidis   +8 more
wiley   +1 more source

Preincisional administration of intravenous or subcutaneous infiltration of low-dose ketamine suppresses postoperative pain after appendectomy

open access: yes, 2011
Azim Honarmand, Mohammadreza Safavi, Hasan KarakyAnesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, IranBackground: Ketamine, an N-methyl-D-aspartate receptor antagonist, can suppress hyperalgesia and ...
A, Safavi M, Honarm, Karaky H
core  

Five-day regimen of intramuscular or subcutaneous self-administered adrenocorticotropic hormone gel for acute exacerbations of multiple sclerosis: a prospective, randomized, open-label pilot trial

open access: yes, 2011
James P Simsarian, Carol Saunders, D Michelle SmithNeurology Center of Fairfax Ltd, Fairfax, VA, USABackground: Despite over 50 years of experience with adrenocorticotropic hormone (ACTH) as a treatment for acute exacerbations of multiple sclerosis ...
James Simsarian   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy